Literature DB >> 581094

Effects of tracheal instillation of natural surfactant in premature lambs. I. Clinical and autopsy findings.

F H Adams, B Towers, A B Osher, M Ikegami, T Fujiwara, M Nozaki.   

Abstract

Ten pairs of twin lambs 118--122 days of gestation were given either natural surfactant or diluent endotracheally before the first breath. By using the premature twin lamb model, we have been able to show that instillation of natural surfactant produced 100% survival for the duration of the study period (2 hr); stable blood gases on room air; lungs that became increasingly compliant while on the respirator; generally well aerated lungs at autopsy; good lung pressure-volume relationships; normal lung surface tension measurements; and histologic evidence of good alveolar expansion with large amounts of free intraluminal phospholipid, no epithelial damage, and no hyaline membranes. It is concluded that tracheal instillation of natural surfactant into the premature lamb protects the lungs from developing many features characteristic of the respiratory distress syndrome.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 581094     DOI: 10.1203/00006450-197808000-00008

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  27 in total

Review 1.  Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome.

Authors:  T A Merritt; M Hallman; R Spragg; G P Heldt; N Gilliard
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

2.  Response to bovine surfactant (surfactant TA) in two different HMD models (lambs and baboons).

Authors:  H Maeta; D Vidyasagar; T Raju; R Bhat; H Matsuda
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

Review 3.  Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.

Authors:  K L Dechant; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

4.  Surfactant replacement therapy for neonatal respiratory distress syndrome.

Authors:  R Dhanireddy
Journal:  Indian J Pediatr       Date:  1990 Nov-Dec       Impact factor: 1.967

Review 5.  Surfactant replacement therapy.

Authors:  M J Kresch; W H Lin; R S Thrall
Journal:  Thorax       Date:  1996-11       Impact factor: 9.139

Review 6.  Surfactant therapy: the current practice and the future trends.

Authors:  Khalid Altirkawi
Journal:  Sudan J Paediatr       Date:  2013

7.  Searching for better animal models of BPD: a perspective.

Authors:  Namasivayam Ambalavanan; Rory E Morty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-23       Impact factor: 5.464

Review 8.  Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future.

Authors:  Smeeta Sardesai; Manoj Biniwale; Fiona Wertheimer; Arlene Garingo; Rangasamy Ramanathan
Journal:  Pediatr Res       Date:  2016-10-05       Impact factor: 3.756

Review 9.  Paediatrics--Part I.

Authors:  B L Priestley; C J Harrison; M P Gerrard; A Gibson
Journal:  Postgrad Med J       Date:  1993-03       Impact factor: 2.401

Review 10.  Surfactant treatment for respiratory distress syndrome: a review.

Authors:  C J Morley
Journal:  J R Soc Med       Date:  1984-09       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.